These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 7608251

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Difference in dominant negative activities between mutant thyroid hormone receptors alpha1 and beta1 with an identical truncation in the extreme carboxyl-terminal tau4 domain.
    Nishiyama K, Andoh S, Kitahara A, Natsume H, Mikami T, Genma R, Nakamura H.
    Mol Cell Endocrinol; 1998 Mar 16; 138(1-2):95-104. PubMed ID: 9685218
    [Abstract] [Full Text] [Related]

  • 23. High affinity and specificity of dimeric binding of thyroid hormone receptors to DNA and their ligand-dependent dissociation.
    Miyamoto T, Suzuki S, DeGroot LJ.
    Mol Endocrinol; 1993 Feb 16; 7(2):224-31. PubMed ID: 8469235
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In vivo genomic footprinting of thyroid hormone-responsive genes in pituitary tumor cell lines.
    Kim SW, Ahn IM, Larsen PR.
    Mol Cell Biol; 1996 Aug 16; 16(8):4465-77. PubMed ID: 8754847
    [Abstract] [Full Text] [Related]

  • 26. Two consecutive nucleotide substitutions resulting in the T3 receptor beta gene resulting in an 11-amino acid truncation in a patient with generalized resistance to thyroid hormone.
    Miyoshi Y, Nakamura H, Sasaki S, Tagami T, Misaki T, Konishi J, Nakao K.
    Mol Cell Endocrinol; 1995 Oct 30; 114(1-2):9-17. PubMed ID: 8674855
    [Abstract] [Full Text] [Related]

  • 27. Two thyroid hormone response elements are present in the promoter of human thyroid hormone receptor beta 1.
    Suzuki S, Miyamoto T, Opsahl A, Sakurai A, DeGroot LJ.
    Mol Endocrinol; 1994 Mar 30; 8(3):305-14. PubMed ID: 8015548
    [Abstract] [Full Text] [Related]

  • 28. Dominant-negative mutant thyroid hormone receptors prevent transcription from Xenopus thyroid hormone receptor beta gene promoter in response to thyroid hormone in Xenopus tadpoles in vivo.
    Ulisse S, Esslemont G, Baker BS, Krishna V, Chatterjee K, Tata JR.
    Proc Natl Acad Sci U S A; 1996 Feb 06; 93(3):1205-9. PubMed ID: 8577741
    [Abstract] [Full Text] [Related]

  • 29. Identification of naturally occurring dominant negative mutants of thyroid hormone alpha 1 and beta 1 receptors in a human hepatocellular carcinoma cell line.
    Lin KH, Zhu XG, Shieh HY, Hsu HC, Chen ST, McPhie P, Cheng SY.
    Endocrinology; 1996 Oct 06; 137(10):4073-81. PubMed ID: 8828459
    [Abstract] [Full Text] [Related]

  • 30. Transcriptional activity of a mutant thyroid hormone receptor beta in a family with generalized resistance to thyroid hormone.
    Shuto Y, Okazaki T, Wakabayashi I.
    Mol Cell Endocrinol; 1992 Dec 06; 90(1):111-5. PubMed ID: 1301392
    [Abstract] [Full Text] [Related]

  • 31. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes.
    Nagl SB, Nelson CC, Romaniuk PJ, Allison LA.
    Mol Endocrinol; 1995 Nov 06; 9(11):1522-32. PubMed ID: 8584030
    [Abstract] [Full Text] [Related]

  • 32. A mouse model of resistance to thyroid hormone produced by somatic gene transfer of a mutant thyroid hormone receptor.
    Hayashi Y, Mangoura D, Refetoff S.
    Mol Endocrinol; 1996 Jan 06; 10(1):100-6. PubMed ID: 8838149
    [Abstract] [Full Text] [Related]

  • 33. Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors?
    Hayashi Y, Weiss RE, Sarne DH, Yen PM, Sunthornthepvarakul T, Marcocci C, Chin WW, Refetoff S.
    J Clin Endocrinol Metab; 1995 Nov 06; 80(11):3246-56. PubMed ID: 7593433
    [Abstract] [Full Text] [Related]

  • 34. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M, Freedman LP, Li H, Christakos S.
    Mol Endocrinol; 1998 Sep 06; 12(9):1367-79. PubMed ID: 9731705
    [Abstract] [Full Text] [Related]

  • 35. Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone.
    Hayashi Y, Sunthornthepvarakul T, Refetoff S.
    J Clin Invest; 1994 Aug 06; 94(2):607-15. PubMed ID: 8040316
    [Abstract] [Full Text] [Related]

  • 36. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone.
    Safer JD, Langlois MF, Cohen R, Monden T, John-Hope D, Madura J, Hollenberg AN, Wondisford FE.
    Mol Endocrinol; 1997 Jan 06; 11(1):16-26. PubMed ID: 8994184
    [Abstract] [Full Text] [Related]

  • 37. Ligand (T3) dependent and independent effects of thyroid hormone receptors upon human TRH gene transcription in neuroblastoma cells.
    Feng P, Li QL, Satoh T, Wilber JF.
    Biochem Biophys Res Commun; 1994 Apr 15; 200(1):171-7. PubMed ID: 8166684
    [Abstract] [Full Text] [Related]

  • 38. Differential sensitivity of thyroid hormone receptor isoform homodimers and mutant heterodimers to hormone-induced dissociation from deoxyribonucleic acid: its role in dominant negative action.
    Zhu XG, McPhie P, Cheng SY.
    Endocrinology; 1997 Apr 15; 138(4):1456-63. PubMed ID: 9075702
    [Abstract] [Full Text] [Related]

  • 39. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
    Harrus D, Déméné H, Vasquez E, Boulahtouf A, Germain P, Figueira AC, Privalsky ML, Bourguet W, le Maire A.
    Thyroid; 2018 Dec 15; 28(12):1708-1722. PubMed ID: 30235988
    [Abstract] [Full Text] [Related]

  • 40. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity.
    Yagi H, Pohlenz J, Hayashi Y, Sakurai A, Refetoff S.
    J Clin Endocrinol Metab; 1997 May 15; 82(5):1608-14. PubMed ID: 9141558
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.